一年的真实世界经验与mavacamten及其对阻塞性缩性心肌病的生理影响
Daniel Seung Kim1,2,3,4,5, Emily L Chu1, Emily E Keamy-Minor1
1Division of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA, United States.
Frontiers in cardiovascular medicine
|September 24, 2024
概括
马瓦卡门,一种新型心脏肌抑制剂,在阻塞性多变性心肌病 (oHCM) 患者中显示出显著的改善. 现实世界的数据表明安全性和有效性,罕见的不良事件和显著的症状缓解.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 阻塞性生理学 (oHCM) 超性心肌病是一种重要的心血管疾病.
- 心脏肌酸氨基酶抑制剂代表了oHCM的新型治疗类.
研究的目的:
- 评估在oHCM患者中mavacamten的实际安全性和有效性.
- 评估mavacamten对临床参数和患者报告结果的影响.
主要方法:
- 在第三级护理中心对50名oHCM患者接受了mavacamten治疗的回顾性分析.
- 监测心声学参数,纽约心脏协会 (NYHA) 课程和不良事件.
主要成果:
- 观察到的显著改善是墙壁厚度,额叶吐,左心室外流通道阻塞和NYHA类.
- 对心律失常负担和收缩能力的影响最小;左心室喷射率 (LVEF) 的平均下降在临床上无意义.
- 由于LVEF<50%,两名患者需要暂时停止使用mavacamten;不良事件很少发生,并且与mavacamten没有直接联系.
结论:
- 马瓦卡门在治疗oHCM的现实环境中是安全有效的.
- 该药物在该患者队列中显示出显著的临床益处,并具有有利的安全性.
- 多学科的方法为oHCM患者快速获得这种新疗法提供了便利.
相关概念视频
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...


